Abstract
Deaths due to shortage of ventilators and lack of the hospitals’ capacity to deal with rapidly increasing number of Covid19 patients had increased in the initial stages of the pandemic, therefore the research focuses on how to support the paramedics combat Covid19 pandemic, The solution is to develop a method which could provide substitute to the ventilators and relief in hospitals’ capacity to deal with huge number of patients. Heliox is a mixture of helium and oxygen (HeO2), and is an extremely safe and rapid acting therapeutic agent that provides relief in breathing, tightness in the chest, blocked nose, cough, wheezing, fever, and chills. Heliox has proved extremely beneficial in patients with asthma, chronic obstructive pulmonary disease (COPD), bronchiolitis, upper and lower airways obstruction and also diffusion of gases such as CO2 in the critical care. Smart Oral Inhalers with a mixture of Heliox (HeO2), Helium Oxide can be prescribed to the patients with severe breathing problems caused by Covid19, until the availability of the ventilators in the critical care units. These Inhalers can be refilled with the Heliox mixture as required. Furthermore smart inhalers can be remotely connected to an IoT (Internet of Things) cloud medical emergency platforms with M2M (Machine-to-Machine) integration and provide real time data about the patient’s respiratory conditions to the medical centers in order solve the hospital’s capacity issues and arrange ventilators.
Presenters
Zulfiqar AslamSenior Instructor of Innovation, Technology and Entrepreneurship, College of Business and Economics, United Arab Emirates University Al Ain, United Arab Emirates
Details
Presentation Type
Theme
2022 Special Focus—Government and Society Collaborations: Responding to Pandemics
KEYWORDS
Helium Oxide, Smart Oral Inhalers, Ventilators, Pandemic, Internet of Things
